ID

28998

Descrição

A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.

Palavras-chave

Versões (1)
  1. 20/02/2018 20/02/2018 -
Titular dos direitos

GlaxoSmithKline (GSK)

Transferido a

20 de fevereiro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518

Inglês

Swelling assessment No.2

2 Formulários  
Report of physical examination and case clinical description
Descrição

Report of physical examination and case clinical description

Alias
UMLS CUI-1
C0031809
Date of physical examination
Descrição

Date

Tipo de dados

date

Alias
UMLS CUI [1]
C0011008
Was the examination performed by a member of study personnel during the extensive swelling period :
Descrição

Examiner

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0025082
Date when the swelling was first considered to be extensive:
Descrição

Date of first extensive swelling

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
If occurring within 24 hours after vaccination, please specify how long after vaccination:
Descrição

Date of fist extensive swelling

Tipo de dados

integer

Unidades de medida
  • hours
Alias
UMLS CUI [1,1]
C0038999
UMLS CUI [1,2]
C2700396
UMLS CUI [1,3]
C0205231
UMLS CUI [1,4]
C0011008
hours
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
Descrição

Swelling case description

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0449437
UMLS CUI [1,2]
C0678257
UMLS CUI [1,3]
C0038999
Voltar ao início da página

Similar models

Swelling assessment No.2

2 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Date
Item
Date of physical examination
date
C0011008 (UMLS CUI [1])
Examiner
Item
Was the examination performed by a member of study personnel during the extensive swelling period :
boolean
C0025082 (UMLS CUI [1])
Date of first extensive swelling
Item
Date when the swelling was first considered to be extensive:
date
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Date of fist extensive swelling
Item
If occurring within 24 hours after vaccination, please specify how long after vaccination:
integer
C0038999 (UMLS CUI [1,1])
C2700396 (UMLS CUI [1,2])
C0205231 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Swelling case description
Item
Please give a clinical description of the observed extensive swelling, including a description of the joint involved and specific associated symptoms. Please mention also eventual diagnostic(s)
text
C0449437 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
C0038999 (UMLS CUI [1,3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial